Mutlu Karkucak

Mutlu Karkucak

Auto-generated profile, based on publicly available information

Mutlu Karkucak

Genetic Diseases Assessment Center, Istinye University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2012 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MKMutlu Karkucak
Mutlu Karkucak
TYTahsin Yakut
Tahsin Yakut
VOVildan Ozkocaman
Vildan Ozkocaman
FOFahir Ozkalemkas
Fahir Ozkalemkas
RARidvan Ali
Ridvan Ali
GOGokhan Ocakoglu
Gokhan Ocakoglu

1 June 2012 in International Journal of Human Genetics
Verified
Journal Article
Closed access
MKMutlu Karkucak
Mutlu Karkucak
TYTahsin Yakut
Tahsin Yakut
TETurkkan Evrensel
Turkkan Evrensel
ADAdem Deligonul
Adem Deligonul
TGTuna Gulten
Tuna Gulten
MCMustafa Canhoroz
Mustafa Canhoroz
Polymorphisms in the X-ray repair cross complementing 1 (XRCC1) gene have been found to be associated with susceptibility to various types of cancers. We investigated the association between the XRCC1 gene Arg399Gln polymorphism and the susceptibility to lung cancer in Turkish patients. To determine the association of this polymorphism with the risk of lung cancer in Turkish patients, a hospital-based case-control study was designed, involving 67 patients with lung cancer and 60 control subjects with no cancer history who were matched for age and gender. XRCC1 genotypes (Arg/Arg, Arg/Gln, and Gln/Gln) were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis on genomic DNA. No statistically significant relationship was determined between the lung cancer and control groups (p>0.05). Among the patients, 61% were Arg/Arg, 28% were Arg/Gln, and 11% were Gln/Gln. Among the controls, 50% were Arg/Arg, 38% were Arg/Gln, and 12% were Gln/Gln. There was no difference in the distribution of XRCC1 genotypes or the frequencies of the Arg (75% versus 69%) and Gln (25% versus 31%) alleles between the lung cancer patients and controls. Our results suggest that the XRCC1 gene Arg399Gln polymorphism is not associated with an increased risk for the development of lung cancer in Turkish patients.

1 November 2017 in Revista Brasileira de Reumatologia (English Edition)
Verified
Journal Article
Open access
MÖMustafa Ferhat Öksuz
Mustafa Ferhat Öksuz
MKMutlu Karkucak
Mutlu Karkucak
OGOrhan Görukmez
Orhan Görukmez
GOGökhan Ocakoğlu
Gökhan Ocakoğlu
AYAbdulmecit Yıldız
Abdulmecit Yıldız
KDKamil Dilek
Kamil Dilek
AimVarious mutations have been identified in the Mediterranean fever (MEFV) gene which is reported to be responsible from Familial Mediterranean fever (FMF). In our study, we aimed to determine the frequency of the MEFV mutations in our region and to investigate the impact of G138G (rs224224, c.414A>G) and A165A (rs224223, c.495C>A) gene polymorphisms on the clinical findings of the disease.MethodsOne hundred and sixteen patients diagnosed with FMF and 95 control subjects were included in this study. We used the DNA sequence analysis method to identify the most prevailing 10 mutations located in exon 2 and 10 of MEFV gene.ResultsAs a result of the MEFV mutation analysis, the most common mutation was the M694V mutation allele with a frequency rate of 41.8%. When the patients group and control group were compared in terms of frequency of both polymorphic alleles (G polymorphic allele, observed in G138G and the A polymorphic allele, observed in A165A), the variation was observed to be statistically significant (p0.05).ConclusionsTo our knowledge, our study is the first study in the Southern Marmara region that reports the frequency of MEFV mutations. Our findings imply that the polymorphisms of G138G and A165A may have an impact on progress of the disease. We think that more studies, having higher number of cases and investigating the polymorphisms of MEFV gene, are needed

1 March 2015 in International Journal of Human Genetics
Verified
Journal Article
Closed access
MTMehmet Ture
Mehmet Ture
TYTahsin Yakut
Tahsin Yakut
ADAdem Deligonul
Adem Deligonul
MKMutlu Karkucak
Mutlu Karkucak
SSSebnem Ozemri Sag
Sebnem Ozemri Sag
TETurkkan Evrensel
Turkkan Evrensel
Several studies have shown relationships between predisposition to various types of cancer and polymorphisms of the fibroblast growth factor receptor 4 (FGFR4) gene. In the present study, researchers investigated the relationship between primary lung cancer and (PLC) FGFR4 Gly388Arg polymorphism in regard to tendency, histopathologic sub-type, early onset, and metastatic status. The present study included 124 PLC patients and 100 healthy controls. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to identify gene polymorphism of FGFR4 Gly388Arg. Statistical significance was considered when p < 0.05, and a statistically significant difference was not found in FGFR-4 polymorphism between the patient group and control group in regard to tendency, histopathologic sub-type, early onset, and metastatic status (p> 0.05). The findings in this study demonstrated that there was no relationship between polymorphism of FGFR4 Gly388Arg gene and PLC. However, these results should be confirmed in larger studies and in specific histopathological sub-types of PLC.


21 September 2012 in Tuberk Toraks
Verified
Journal Article
Closed access
DYDilber Yılmaz
Dilber Yılmaz
MKMutlu Karkucak
Mutlu Karkucak
FCFunda Coskun
Funda Coskun
TYTahsin Yakut
Tahsin Yakut
EUEsra Kunt Uzaslan
Esra Kunt Uzaslan
Etiology of sarcoidosis is unknown but the prevalence of disease in different ethnic groups and identical twins, family characteristics indicate that genetic predisposition is a possible factor. The angiotensin-converting enzyme (ACE) has been implicated in the pahophysiology of sarcoidosis. The aim of this study is to investigate the influence of a polymorphism in I/D (Insertion/Deletion) of the ACE gene on the susceptibility to sarcoidosis. Our study included 70 Turkish patients who had histopathological diagnosis of sarcoidosis and 69 healthy age and sex matched control subjects. Polymerase chain reaction was used for analysing an I/D polymorphism in the gene coding for ACE. Genotyping was done according to bands that were formed on the agarose gel electrophoresis. Chi-square test was used for statistical analysis and p< 0.05 was accepted as significance. Although the D allele was more frequent in the sarcoidosis patients group, the frequency of the D allele was 67% and 54% respectively in the sarcoidosis and the control group. No significant difference in allele frequencies of I/I, I/D, D/D polymorphisms was observed between the sarcoidosis and control group (p> 0.05). Similarly allele frequencies of I/I, I/D, D/D polymorphisms was not different between sarcoidosis patients with extrapulmonary involvement and sarcoidosis patients without extrapulmonary involvement (p> 0.05). Our findings have showed that contribution of ACE gene polymorphisms to susceptibility of disease development in Turkish sarcoidosis patients is not different from the healthy control subjects.